- Home
- NMRA vs PKOH Comparison
NMRA vs PKOH Comparison
Compare NMRA & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- PKOH
- Stock Information
- Founded
- NMRA 2019
- PKOH 1907
- Country
- NMRA United States
- PKOH United States
- Employees
- NMRA N/A
- PKOH N/A
- Industry
- NMRA
- PKOH Industrial Specialties
- Sector
- NMRA
- PKOH Industrials
- Exchange
- NMRA Nasdaq
- PKOH Nasdaq
- Market Cap
- NMRA 291.5M
- PKOH 299.9M
- IPO Year
- NMRA 2023
- PKOH N/A
- Fundamental
- Price
- NMRA $2.50
- PKOH $20.45
- Analyst Decision
- NMRA Buy
- PKOH
- Analyst Count
- NMRA 8
- PKOH 0
- Target Price
- NMRA $7.43
- PKOH N/A
- AVG Volume (30 Days)
- NMRA 2.3M
- PKOH 17.7K
- Earning Date
- NMRA 11-06-2025
- PKOH 11-05-2025
- Dividend Yield
- NMRA N/A
- PKOH 2.40%
- EPS Growth
- NMRA N/A
- PKOH 41.57
- EPS
- NMRA N/A
- PKOH 2.02
- Revenue
- NMRA N/A
- PKOH $1,611,500,000.00
- Revenue This Year
- NMRA N/A
- PKOH $0.23
- Revenue Next Year
- NMRA N/A
- PKOH $3.07
- P/E Ratio
- NMRA N/A
- PKOH $10.34
- Revenue Growth
- NMRA N/A
- PKOH N/A
- 52 Week Low
- NMRA $0.61
- PKOH $15.52
- 52 Week High
- NMRA $14.09
- PKOH $34.50
- Technical
- Relative Strength Index (RSI)
- NMRA 68.71
- PKOH 53.47
- Support Level
- NMRA $1.68
- PKOH $20.00
- Resistance Level
- NMRA $2.72
- PKOH $20.98
- Average True Range (ATR)
- NMRA 0.20
- PKOH 0.65
- MACD
- NMRA 0.08
- PKOH 0.03
- Stochastic Oscillator
- NMRA 81.89
- PKOH 73.35
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.